Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-17

Clinical Trial Update: Lacrima VR for Dry Eye Disease and Meibomian Gland Dysfunction [NA]

View source ↗

Summary

Lacrima VR is being studied for dry eye disease and meibomian gland dysfunction. The trial is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lacrima VR

Snippet

Sponsor: Demaod Ltd | Conditions: Dry Eye, Dry Eye Syndromes | NA | Status: NOT_YET_RECRUITING